Details of the Drug Pharmacogenomic Perturbation Atlas

General Information of Drug (ID: DMN1RMO)

Drug Name
Stanozolol Drug Info
Synonyms
stanozolol; Androstanazole; Winstrol; Androstanazol; 10418-03-8; Stromba; Stanazolol; Winstrol Depot; Strombaject; Tevabolin; Estazol; Winstroid; Anabol; Winstrol V; Estanozolol; Stanozololum; Stanozolo [DCIT]; Androstanazole (VAN); WIN 14833; Stanozolol (1'H form); Winstrol-V; Stanozololum [INN-Latin]; Estanozolol [INN-Spanish]; UNII-4R1VB9P8V3; Androstanazolestanazol; HSDB 3185; Stanozolol (2'H form); EINECS 233-894-8; NSC 43193; NSC 233046; 4R1VB9P8V3; CHEBI:9249; 2'H-Androst-2-eno(3,2-c)pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-
Cross-matching ID
PubChem CID
25249
ChEBI ID
CHEMBL9249
CAS Number
CAS 302-96-5
TTD Drug ID
D08QKJ

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
Term Name NES FDR q-val Tag % Leading Edge Genes
Antigen processing and presentation 2.02 1.88e-2 60/78 (76.92%) HLA-C;HLA-F;HLA-G;...
Autoimmune thyroid disease 2.00 9.41e-3 46/53 (86.79%) HLA-C;HLA-F;HLA-G;...
Allograft rejection 1.97 6.27e-3 32/38 (84.21%) HLA-C;HLA-F;HLA-G;...
Porphyrin and chlorophyll metabolism 1.96 4.71e-3 23/43 (53.49%) ALAS2;UGT2B28;UGT2B4;...
Bile secretion 1.91 7.53e-3 68/90 (75.56%) CA2;ABCG2;ADCY2;...
Steroid hormone biosynthesis 1.89 1.10e-2 43/61 (70.49%) AKR1C3;HSD11B1;SRD5A1;...
Metabolism of xenobiotics by cytochrome P450 1.87 9.41e-3 49/77 (63.64%) HSD11B1;UGT2B28;CYP1A1;...
Graft-versus-host disease 1.72 4.82e-2 32/42 (76.19%) HLA-C;HLA-F;HLA-G;...
PPAR signaling pathway 1.68 4.99e-2 66/74 (89.19%) PLIN2;FABP7;PPARG;...
Citrate cycle (TCA cycle) -2.25 0.00e+0 30/30 (100%) MDH1;ACO2;IDH1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Ewing sarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SK-ES-1 CVCL_0627 Homo sapiens 1.11uM - 10uM 24H
Brain
Glioma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
GI-1 CVCL_1230 Homo sapiens 1.11uM - 10uM 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
MDA-MB-468 CVCL_0419 Homo sapiens 1.11uM - 10uM 24H
Breast ductal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
T-47D CVCL_0553 Homo sapiens 1.11uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SNU-407 CVCL_5004 Homo sapiens 1.11uM - 10uM 24H
Endometrium
Endometrial adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEC-108 CVCL_2926 Homo sapiens 1.11uM - 10uM 24H
HEC-1-A CVCL_0293 Homo sapiens 1.11uM - 10uM 24H
HEC-251 CVCL_2928 Homo sapiens 1.11uM - 10uM 24H
HEC-265 CVCL_2929 Homo sapiens 1.11uM - 10uM 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CJM CVCL_U797 Homo sapiens 1.11uM - 10uM 24H
Liver
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HuH-7 CVCL_0336 Homo sapiens 10uM 72H
JHH-5 CVCL_1320 Homo sapiens 1.11uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H1573 CVCL_1483 Homo sapiens 1.11uM - 10uM 24H
NCI-H838 CVCL_1594 Homo sapiens 1.11uM - 10uM 24H
Lung squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BEN CVCL_1081 Homo sapiens 1.11uM - 10uM 24H
HCC95 CVCL_1276 Homo sapiens 1.11uM - 10uM 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H2110 CVCL_1529 Homo sapiens 1.11uM - 10uM 24H
Muscle
Rhabdomyosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-204 CVCL_0134 Homo sapiens 1.11uM - 10uM 24H
Ovary
Ovarian clear cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
OVTOKO CVCL_3114 Homo sapiens 1.11uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
22Rv1 CVCL_1045 Homo sapiens 1.11uM - 10uM 24H
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
IGR-37 CVCL_1303 Homo sapiens 1.11uM - 10uM 24H
Mel-HO CVCL_1402 Homo sapiens 1.11uM - 10uM 24H
SH-4 CVCL_1692 Homo sapiens 1.11uM - 10uM 24H
Urinary bladder
Bladder transitional cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CAL-29 CVCL_1109 Homo sapiens 1.11uM - 10uM 24H